Markedly Elevated CA 19‐9 in ANA/ASMA‐Negative IgG4‐Related Autoimmune Hepatitis With Concomitant Pancreatitis: A Case Report
Case Reports in Gastrointestinal Medicine · 2026-01 · 2026 (1)
DOI: 10.1155/crgm/3494971 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Gastrointestinal Medicine, online erschienen am 19.04.2026. Verfasst von Hunter Scott und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA, clevelandclinic.org. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
IgG4‐related disease (IgG4‐RD) can involve the liver and pancreas and may present without conventional autoimmune hepatitis (AIH) autoantibodies, creating diagnostic delay unless IgG4 testing and tissue immunostaining are pursued. We describe an older man with acute hepatocellular injury and marked hyperbilirubinemia who was negative for antinuclear (ANA) and antismooth muscle (ASMA) antibodies but had markedly elevated serum IgG4 and IgG4‐positive plasma cell infiltration on liver biopsy, consistent with IgG4‐related autoimmune hepatitis (IgG4‐AIH). Case Presentation A man in his 80s presented with abdominal pain followed by progressive jaundice and pruritus, with acute hepatocellular injury and hyperbilirubinemia. Evaluation showed negative ANA and ASMA, elevated total IgG (2166 mg/dL) and IgG4 (442.5 mg/dL), CA 19‐9 1268 U/mL, and CT/MRCP findings consistent with pancreatitis without biliary obstruction or mass. HFE analysis showed compound heterozygosity. Liver biopsy demonstrated interface hepatitis with plasma cell–rich inflammation and increased IgG4‐positive plasma cells (up to 58 per high‐power field), supporting IgG4‐AIH. Minimal iron deposition on biopsy favored inflammation‐related iron study abnormalities rather than primary hemochromatosis. The pancreatic findings were most consistent with probable Type 1 autoimmune pancreatitis. Prednisone 40 mg daily led to improvement, with normalization of transaminases and total bilirubin by Day 57 (approximately 8 weeks) in available follow‐up testing.
Conclusion
IgG4‐AIH is diagnostically challenging, particularly in seronegative presentations. Unexpectedly high CA 19‐9 may be seen in IgG4‐RD, which may mimic malignancy. In atypical presentations such as those occurring in older adults without conventional antibody positivity or with concurrent pancreatitis on imaging, clinicians should promptly consider early biopsy with immunostaining to avoid diagnostic delay and enable timely steroid treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA, clevelandclinic.org.
ORCID-Profile: Hunter Scott, Samuel Reiss
Zitieren
APA
Scott, H., & Reiss, S. (2026). Markedly Elevated CA 19‐9 in ANA/ASMA‐Negative IgG4‐Related Autoimmune Hepatitis With Concomitant Pancreatitis: A Case Report. Case Reports in Gastrointestinal Medicine, 2026(1). https://doi.org/10.1155/crgm/3494971
Vancouver
Scott H, Reiss S. Markedly Elevated CA 19‐9 in ANA/ASMA‐Negative IgG4‐Related Autoimmune Hepatitis With Concomitant Pancreatitis: A Case Report. Case Reports in Gastrointestinal Medicine. 2026;2026(1). doi:10.1155/crgm/3494971
BibTeX
@article{Scott2026,
author = {Scott, Hunter and Reiss, Samuel},
title = {Markedly Elevated CA 19‐9 in ANA/ASMA‐Negative IgG4‐Related Autoimmune Hepatitis With Concomitant Pancreatitis: A Case Report},
journal = {Case Reports in Gastrointestinal Medicine},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crgm/3494971}
}
EUVIMED